St. Jude executes exclusive license for vaccine to an Ohio biopharma company

Blue Water Vaccines Inc., an Ohio-based biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine developed by a researcher at St. Jude Children’s Research Hospital. According to this announcement, acute otitis media caused by Streptococcus pneumoniae remains one of the most common infectious diseases worldwide despite widespread vaccination.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.